Bilaketaren emaitzak - Prasad, Vikas

PSMA Theranostics: Is the Time Ripe to Pave the Way to Further Tumor Entities? nork Brenner, Winfried, Strobel, Joachim, Prasad, Vikas

Testu osoa Testu osoa Testu osoa

Nephrotoxicity after radionuclide therapies nork Parihar, Ashwin Singh, Chopra, Sejal, Prasad, Vikas

Testu osoa Testu osoa Testu osoa

The impact of (18) F-FET PET-CT on target definition in image-guided stereotactic radiotherapy in patients with skull base lesions nork Badakhshi, Harun, Graf, Reinhold, Prasad, Vikas, Budach, Volker

Testu osoa Testu osoa Testu osoa

Octreotide Does Not Inhibit Proliferation in Five Neuroendocrine Tumor Cell Lines nork Exner, Samantha, Prasad, Vikas, Wiedenmann, Bertram, Grötzinger, Carsten

Testu osoa Testu osoa Testu osoa

mTOR Inhibitors as Radiosensitizers in Neuroendocrine Neoplasms nork Exner, Samantha, Arrey, Gerard, Prasad, Vikas, Grötzinger, Carsten

Testu osoa Testu osoa Testu osoa

Effect of Peptide Receptor Radionuclide Therapy on Somatostatin Receptor Status and Glucose Metabolism in Neuroendocrine Tumors: Intraindividual Comparison of Ga-68 DOTANOC PET/CT... nork Oh, Sowon, Prasad, Vikas, Lee, Dong Soo, Baum, R. P.

Testu osoa Testu osoa Testu osoa

Can Met-PET/CT Predict Sporadic Multiglandular Hyperparathyroidism? Report of a Case and Review of the Literature nork Hillenbrand, Andreas, Lemke, Johannes, Henne-Bruns, Doris, Beer, Ambros J., Prasad, Vikas

Testu osoa Testu osoa Testu osoa

Parental beliefs about children's teething in Udaipur, India: a preliminary study nork Kakatkar, Gauri, Nagarajappa, Ramesh, Bhat, Nagesh, Prasad, Vikas, Sharda, Archana, Asawa, Kailash

Testu osoa

In Comparison to PSA, Interim Ga-68-PSMA PET/CT Response Evaluation Based on Modified RECIST 1.1 After 2(nd) Cycle Is Better Predictor of Overall Survival of Prostate Cancer Patien... nork Prasad, Vikas, Huang, Kai, Prasad, Sonal, Makowski, Marcus R., Czech, Norbert, Brenner, Winfried

Testu osoa Testu osoa Testu osoa

Effect of Peptide Dose on Radiation Dosimetry for Peptide Receptor Radionuclide Therapy with (177)Lu-DOTATOC: A Pilot Study nork Prasad, Vikas, Prasad, Sonal, Lehnert, Wencke, Brenner, Winfried, Kai, Huang, Bronzel, Marcus, Kluge, Andreas

Testu osoa Testu osoa Testu osoa

Neoadjuvant peptide receptor radionuclide therapy for an inoperable neuroendocrine pancreatic tumor nork Kaemmerer, Daniel, Prasad, Vikas, Daffner, Wolfgang, Hörsch, Dieter, Klöppel, Günter, Hommann, Merten, Baum, Richard P

Testu osoa Testu osoa Testu osoa

A Physiologically Based Pharmacokinetic Model for In Vivo Alpha Particle Generators Targeting Neuroendocrine Tumors in Mice nork Zaid, Nouran R. R., Kletting, Peter, Winter, Gordon, Prasad, Vikas, Beer, Ambros J., Glatting, Gerhard

Testu osoa Testu osoa Testu osoa

(68)Ga-PSMA-PET/CT for the evaluation of liver metastases in patients with prostate cancer nork Damjanovic, Jonathan, Janssen, Jan-Carlo, Prasad, Vikas, Diederichs, Gerd, Walter, Thula, Brenner, Winfried, Makowski, Marcus R.

Testu osoa Testu osoa Testu osoa

Accuracy of standard clinical 3T prostate MRI for pelvic lymph node staging: Comparison to(68)Ga-PSMA PET-CT nork Meißner, Sebastian, Janssen, Jan-Carlo, Prasad, Vikas, Diederichs, Gerd, Hamm, Bernd, Brenner, Winfried, Makowski, Marcus R.

Testu osoa Testu osoa Testu osoa

Predictors Of Seroconversion Following COVID-19 Vaccination nork Chiarella, Sergio, Jenkins, Sarah, Smith, Carin, Ahluwalia, Vaibhav, Prasad, Vikas, Iyer, Vivek, Theel, Elitza, Joshi, Avni

Testu osoa Testu osoa

Clinical characteristics of subjects with lack of seroconversion following COVID-19 vaccination nork Ahluwalia, Vaibhav, Iyer, Vivek, Jenkins, Sarah, Smith, Carin, Theel, Elitza, Iyer, Tanmay, Prasad, Vikas, Chiarella, Sergio

Testu osoa Testu osoa

Comparing of IRS and Her2 as immunohistochemical scoring schemes in gastroenteropancreatic neuroendocrine tumors nork Kaemmerer, Daniel, Peter, Luisa, Lupp, Amelie, Schulz, Stefan, Sänger, Jörg, Baum, Richard Paul, Prasad, Vikas, Hommann, Merten

Testu osoa Testu osoa

Potential of asphericity as a novel diagnostic parameter in the evaluation of patients with (68)Ga-PSMA-HBED-CC PET-positive prostate cancer lesions nork Meißner, Sebastian, Janssen, Jan-Carlo, Prasad, Vikas, Brenner, Winfried, Diederichs, Gerd, Hamm, Bernd, Hofheinz, Frank, Makowski, Marcus R.

Testu osoa Testu osoa Testu osoa

Contemporary options and future perspectives: three examples highlighting the challenges in testicular cancer imaging nork Wakileh, Gamal Anton, Ruf, Christian, Heidenreich, Axel, Dieckmann, Klaus-Peter, Lisson, Catharina, Prasad, Vikas, Bolenz, Christian, Zengerling, Friedemann

Testu osoa Testu osoa Testu osoa

Comparison of Choi, RECIST and Somatostatin Receptor PET/CT Based Criteria for the Evaluation of Response and Response Prediction to PRRT nork Zwirtz, Kevin, Hardt, Juliane, Acker, Güliz, Baur, Alexander D. J., Pavel, Marianne, Huang, Kai, Brenner, Winfried, Prasad, Vikas

Testu osoa Testu osoa Testu osoa